Elevance Health Inc. (NYSE: ELV) is a leading health insurance provider in the United States. Elevance Health offers a wide range of health plans and services, including medical, pharmacy, dental, and vision coverage. It serves millions of members across various states through its affiliated health plans.
Key Takeaways:
- Elevance Health Inc. stock shows promising growth potential over the next three decades
- Projected Compound Annual Growth Rate (CAGR) of approximately 11.5% from 2024 to 2050
- Factors influencing stock performance include healthcare reform, technological innovation, and market expansion
- Long-term investors may find Elevance Health an attractive option for portfolio growth
Overview of Elevance Health Inc.
Elevance Health, Inc. (NYSE: ELV) is a leading American health insurance provider. Originally founded in 1946 as Anthem, Inc., the company underwent a name change to Elevance Health in 2022 to better reflect its evolving mission and strategy. Elevance Health is the largest for-profit managed health care company in the Blue Cross Blue Shield Association, serving over 46.8 million members through its affiliated health plans.
Elevance Health Inc. Company Profile
| Country | United States |
| Ticker Symbol | ELV |
| Exchange | NYSE |
| Founded | 1946 |
| IPO Date | 2001 |
| Industry | Health Care |
| Sector | Financial Services |
| Employees | 1,04,900 |
| CEO | Gail Koziara Boudreaux |
| Market Cap (July 10, 2024) | $123.00 billion |
| Website | Elevance Health |
Elevance Health Inc. (ELV) Balance Sheet Analysis
Elevance Health Inc.’s 2023 balance sheet shows robust growth. Total assets increased 6% to $108.93 billion, while total liabilities rose 4.7% to $69.52 billion. The company’s equity position strengthened, growing 8.5% to $39.41 billion.
Total debt increased modestly to $25.12 billion, up 4.2% from 2022. Net debt rose more significantly, up 11.2% to $18.59 billion. However, net tangible assets saw a dramatic 140.5% increase to $3.72 billion.
The company’s asset growth outpaced its debt increase, indicating a healthy financial position. The substantial improvement in net tangible assets suggests enhanced operational efficiency or successful acquisitions.
Overall, Elevance Health’s 2023 balance sheet reflects a company in expansion mode, effectively managing its debt while strengthening its equity position and asset base.
Balance Sheet Data Source: finance.yahoo
Elevance Health Inc. Stock Price History
Elevance Health Inc. (NYSE: ELV) had its IPO in the year 2001. Elevance Health (ELV) has undergone one stock split in its history. On June 1, 2005, the company implemented a 2-for-1 split, doubling the number of shares. One share purchased before 2005 would equal two shares today.1
As of July 9, 2024, the stock price stands at $529.24.
ELV Stock Price Forecast 2024
For the remainder of 2024, we anticipate Elevance Health stock to maintain its upward momentum. The company’s strong market position and strategic initiatives are likely to drive growth. We project a modest increase from the current price of $529.24.
Elevance Health’s focus on digital transformation and telehealth services could be key drivers in 2024. The company’s investments in AI-driven health management solutions may start showing returns, potentially attracting tech-savvy investors and boosting stock value.
| Year | Low Price | Average Price | High Price |
|---|---|---|---|
| 2024 | $460.00 | $545.00 | $570.00 |
Our forecast suggests a potential growth of approximately 3% by the end of 2024, with an average price of $545.00.
ELV Stock Price Forecast 2025
In 2025, we expect Elevance Health to continue its growth trajectory. The company’s focus on innovation and expanding its digital health offerings could be key drivers.
The potential implementation of new healthcare policies following the 2024 elections might create opportunities for Elevance Health. The company’s adaptability to regulatory changes and its strong presence in government-sponsored health plans could positively influence investor sentiment and stock performance.
| Year | Low Price | Average Price | High Price |
|---|---|---|---|
| 2025 | $570.00 | $605.00 | $640.00 |
We project a growth of about 11% from 2024, with the average price reaching $605.00.
ELV Stock Price Forecast 2026
The year 2026 could see Elevance Health further strengthening its market position. Potential healthcare policy changes and technological advancements may contribute to stock value appreciation.
Elevance Health’s ongoing efforts in preventive care and personalized health management could start yielding significant results by 2026. The company’s data-driven approach to reducing healthcare costs while improving outcomes may attract more institutional investors, potentially driving up stock prices.
| Year | Low Price | Average Price | High Price |
|---|---|---|---|
| 2026 | $630.00 | $675.00 | $720.00 |
Our forecast indicates a growth of approximately 11.5% from 2025, with an average price of $675.00.
ELV Stock Price Forecast 2027
In 2027, Elevance Health may benefit from its long-term strategies and investments in healthcare innovation. We anticipate continued steady growth.
The increasing adoption of value-based care models could significantly benefit Elevance Health by 2027. The company’s early investments in this area may start paying off, potentially leading to improved profit margins and higher investor confidence in the stock.
| Year | Low Price | Average Price | High Price |
|---|---|---|---|
| 2027 | $700.00 | $755.00 | $810.00 |
Our projections show a potential increase of about 11.8% from 2026, with the average price reaching $755.00.
ELV Stock Price Forecast 2028
As we move into 2028, Elevance Health’s stock may continue to appreciate, driven by its expanding market share and improved operational efficiencies.
By 2028, Elevance Health’s investments in blockchain technology for secure health data management could start showing significant returns. This could lead to improved operational efficiency and data security, potentially attracting more customers and boosting investor confidence.
| Year | Low Price | Average Price | High Price |
|---|---|---|---|
| 2028 | $780.00 | $845.00 | $910.00 |
We forecast a growth of approximately 11.9% from 2027, with an average price of $845.00.
ELV Stock Price Forecast 2029
In 2029, Elevance Health could see its stock value rise further as it capitalizes on emerging healthcare trends and technologies.
The aging population in the U.S. could significantly boost Elevance Health’s Medicare Advantage business by 2029. The company’s strategic focus on this growing market segment may lead to increased revenue and potentially higher stock valuations.
| Year | Low Price | Average Price | High Price |
|---|---|---|---|
| 2029 | $870.00 | $945.00 | $1,020.00 |
Our analysis suggests a growth of about 11.8% from 2028, with the average price reaching $945.00.
ELV Stock Price Forecast 2030
As we enter a new decade, Elevance Health’s stock may continue its upward trend, potentially benefiting from long-term healthcare industry transformations.
By 2030, Elevance Health’s investments in genomic medicine and personalized healthcare could start yielding significant results. This could give the company a competitive edge in the market, potentially leading to increased market share and higher stock valuations.
| Year | Low Price | Average Price | High Price |
|---|---|---|---|
| 2030 | $970.00 | $1,055.00 | $1,140.00 |
We project a growth of approximately 11.6% from 2029, with an average price of $1,055.00.
Related: Medtronic plc (MDT) Stock Forecast & Price Prediction
ELV Stock Price Forecast 2031
In 2031, Elevance Health’s stock may see continued appreciation, driven by its adaptive business strategies and market expansion efforts.
The potential expansion of Elevance Health into new international markets could be a significant growth driver by 2031. The company’s experience in managing complex health systems could be valuable in emerging markets, potentially leading to new revenue streams and increased investor interest.
| Year | Low Price | Average Price | High Price |
|---|---|---|---|
| 2031 | $1,080.00 | $1,175.00 | $1,270.00 |
Our forecast indicates a growth of about 11.4% from 2030, with the average price reaching $1,175.00.
ELV Stock Price Forecast 2032
As we move further into the 2030s, Elevance Health’s stock may continue to show strong performance, potentially benefiting from its established market position and innovative healthcare solutions.
By 2032, Elevance Health’s long-term investments in AI and machine learning for predictive health analytics could start showing significant returns. This could lead to improved health outcomes for members and reduced costs for the company, potentially boosting profitability and stock value.
| Year | Low Price | Average Price | High Price |
|---|---|---|---|
| 2032 | $1,200.00 | $1,310.00 | $1,420.00 |
We project a growth of approximately 11.5% from 2031, with an average price of $1,310.00.
ELV Stock Price Forecast 2033
In 2033, Elevance Health’s stock may continue its upward trend, potentially driven by its ability to adapt to evolving healthcare needs and market demands.
The increasing focus on mental health and wellness could benefit Elevance Health by 2033. The company’s investments in comprehensive mental health solutions and integration of mental health into primary care could lead to increased market share and potentially higher stock valuations.
| Year | Low Price | Average Price | High Price |
|---|---|---|---|
| 2033 | $1,340.00 | $1,460.00 | $1,580.00 |
Our analysis suggests a growth of about 11.5% from 2032, with the average price reaching $1,460.00.
ELV Stock Price Forecast 2034
As we approach the mid-2030s, Elevance Health’s stock may see continued appreciation, potentially benefiting from its long-term strategies and market expansions.
By 2034, Elevance Health’s investments in virtual and augmented reality for healthcare delivery could start showing significant returns. These technologies could revolutionize telemedicine and remote patient monitoring, potentially giving the company a competitive edge and boosting investor confidence.
| Year | Low Price | Average Price | High Price |
|---|---|---|---|
| 2034 | $1,490.00 | $1,625.00 | $1,760.00 |
We forecast a growth of approximately 11.3% from 2033, with an average price of $1,625.00.
ELV Stock Price Forecast 2035
In 2035, Elevance Health’s stock may continue its growth trajectory, potentially driven by its ability to leverage emerging technologies and healthcare trends.
The potential widespread adoption of precision medicine could significantly benefit Elevance Health by 2035. The company’s early investments in this area could lead to more effective, personalized treatments for members, potentially resulting in improved health outcomes and increased profitability.
| Year | Low Price | Average Price | High Price |
|---|---|---|---|
| 2035 | $1,660.00 | $1,810.00 | $1,960.00 |
Our projections show a potential increase of about 11.4% from 2034, with the average price reaching $1,810.00.
ELV Stock Price Forecast 2036
As we move into the latter half of the 2030s, Elevance Health’s stock may continue to appreciate, potentially benefiting from its established market presence and innovative healthcare solutions.
By 2036, Elevance Health’s investments in quantum computing for complex health data analysis could start yielding significant results. This could lead to breakthrough discoveries in disease prevention and treatment, potentially giving the company a significant competitive advantage and boosting stock value.
| Year | Low Price | Average Price | High Price |
|---|---|---|---|
| 2036 | $1,850.00 | $2,015.00 | $2,180.00 |
We project a growth of approximately 11.3% from 2035, with an average price of $2,015.00.
ELV Stock Price Forecast 2037
In 2037, Elevance Health’s stock may see continued growth, potentially driven by its ability to adapt to changing healthcare landscapes and consumer needs.
The potential integration of advanced robotics in healthcare delivery could benefit Elevance Health by 2037. The company’s investments in this area could lead to improved efficiency in healthcare services, potentially resulting in cost savings and increased profitability, which could positively impact stock value.
| Year | Low Price | Average Price | High Price |
|---|---|---|---|
| 2037 | $2,060.00 | $2,245.00 | $2,430.00 |
Our analysis suggests a growth of about 11.4% from 2036, with the average price reaching $2,245.00.
ELV Stock Price Forecast 2038
As we approach the end of the 2030s, Elevance Health’s stock may continue its upward trend, potentially benefiting from its long-term strategies and market expansions.
By 2038, Elevance Health’s focus on environmental health and its impact on overall wellness could start showing significant returns. The company’s investments in green healthcare initiatives and sustainable practices may attract environmentally conscious consumers and investors, potentially boosting stock value.
| Year | Low Price | Average Price | High Price |
|---|---|---|---|
| 2038 | $2,290.00 | $2,500.00 | $2,710.00 |
We forecast a growth of approximately 11.4% from 2037, with an average price of $2,500.00.
ELV Stock Price Forecast 2039
In 2039, Elevance Health’s stock may continue to appreciate, potentially driven by its ability to leverage advanced technologies and evolving healthcare models.
The potential widespread adoption of brain-computer interfaces for health monitoring could significantly benefit Elevance Health by 2039. The company’s early investments in this cutting-edge technology could lead to revolutionary advancements in neurological health management, potentially resulting in increased market share and higher stock valuations.
| Year | Low Price | Average Price | High Price |
|---|---|---|---|
| 2039 | $2,550.00 | $2,785.00 | $3,020.00 |
Our projections show a potential increase of about 11.4% from 2038, with the average price reaching $2,785.00.
ELV Stock Price Forecast 2040
As we enter a new decade, Elevance Health’s stock may continue its growth trajectory, potentially benefiting from its established market position and innovative healthcare solutions.
By 2040, Elevance Health’s investments in nanotechnology for targeted drug delivery and disease treatment could start showing significant returns. This could lead to more effective treatments with fewer side effects, potentially giving the company a competitive edge and boosting investor confidence.
| Year | Low Price | Average Price | High Price |
|---|---|---|---|
| 2040 | $2,840.00 | $3,100.00 | $3,360.00 |
We project a growth of approximately 11.3% from 2039, with an average price of $3,100.00.
ELV Stock Price Forecast 2050
Looking ahead to 2050, we anticipate significant growth for Elevance Health’s stock, reflecting long-term industry trends, technological advancements, and the company’s strategic positioning.
By 2050, Elevance Health could be at the forefront of integrating advanced biotechnology and artificial intelligence in healthcare. The company’s long-term investments in areas like regenerative medicine, AI-driven health management, and personalized genomic therapies could potentially revolutionize healthcare delivery, significantly boosting its market position and stock value.
Table 18: Elevance Health Stock Price Forecast for 2050
| Year | Low Price | Average Price | High Price |
|---|---|---|---|
| 2050 | $7,150.00 | $7,800.00 | $8,450.00 |
Our long-term forecast suggests a substantial increase, with the average price reaching $7,800.00 by 2050. This represents a growth of about 151.6% from 2040, reflecting an average annual growth rate of approximately 9.7% over the decade.
Conclusion
Our comprehensive analysis of Elevance Health Inc. (NYSE: ELV) stock price from 2024 to 2050 reveals a promising outlook for long-term investors. We project the stock to reach an average price of $7,800.00 by 2050, representing a remarkable growth of about 1373% over 26 years.
The projected Compound Annual Growth Rate (CAGR) of approximately 11.5% from 2024 to 2050 suggests steady and substantial growth over the long term.
FAQs
1. What is the future of ELV share price?
Our forecast suggests a positive long-term outlook for Elevance Health (ELV) share price. Starting from $529.24 in July 2024, we project the stock to reach an average price of $7,800.00 by 2050, representing a growth of about 1373% over 26 years. The projected Compound Annual Growth Rate (CAGR) is approximately 11.5% from 2024 to 2050.
2. What is the ELV share prediction for 2030?
According to our forecast, the average price for ELV shares in 2030 is expected to be $1,055.00, with a low estimate of $970.00 and a high estimate of $1,140.00.
3. What is the ELV 10 year outlook?
Based on our projections, the 10-year outlook for ELV (from 2024 to 2034) is positive. We forecast the stock price to grow from $529.24 in 2024 to an average of $1,625.00 in 2034, representing significant growth over this period.
4. Is ELV a buy, hold, or sell?
We would cautiously categorize ELV as a “Buy” for long-term investors. The forecast suggests a robust Compound Annual Growth Rate (CAGR) of approximately 11.5% from 2024 to 2050, indicating significant long-term growth potential. Elevance Health’s strong market position in the health insurance sector and its focus on innovation in digital health and AI-driven solutions suggest it’s well-positioned for future growth.
5. Who are the major competitors of ELV?
Elevance Health Inc. major competitors include:
- UnitedHealth Group (NYSE: UNH)
- CVS Health Corporation (NYSE: CVS), which owns Aetna
- Cigna Corporation (NYSE: CI)
- Humana Inc. (NYSE: HUM)
- Centene Corporation (NYSE: CNC)
- Molina Healthcare, Inc. (NYSE: MOH)
Disclaimer:
The stock price predictions provided herein are based on historical data, current market trends, and analysis. However, past performance does not guarantee future results. Stock markets are inherently volatile and subject to numerous economic, political, and market factors that can cause rapid and unpredictable fluctuations in stock prices. The information provided is for educational and informational purposes only and should not be construed as financial advice. It is strongly recommended that you consult with a qualified financial advisor before making any investment decisions. Invest responsibly and consider your individual financial situation, risk tolerance, and investment objectives before acting on any information provided.
Source:
